Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$79.7 - $88.13 $300,389 - $332,161
-3,769 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$81.78 - $95.14 $233,073 - $271,149
-2,850 Reduced 43.06%
3,769 $308,000
Q2 2021

Jul 28, 2021

SELL
$85.24 - $94.15 $246,940 - $272,752
-2,897 Reduced 30.44%
6,619 $604,000
Q1 2021

May 04, 2021

SELL
$83.5 - $98.47 $503,672 - $593,971
-6,032 Reduced 38.8%
9,516 $813,000
Q4 2020

Jan 27, 2021

SELL
$78.07 - $94.43 $2.51 Million - $3.03 Million
-32,110 Reduced 67.38%
15,548 $1.47 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $183,829 - $203,658
-2,238 Reduced 4.49%
47,658 $4.14 Million
Q2 2020

Aug 18, 2020

SELL
$80.93 - $91.1 $24,198 - $27,238
-299 Reduced 0.6%
49,896 $4.36 Million
Q1 2020

May 18, 2020

BUY
$70.67 - $99.01 $50,882 - $71,287
720 Added 1.46%
50,195 $4.14 Million
Q4 2019

Feb 11, 2020

SELL
$84.35 - $95.37 $6,326 - $7,152
-75 Reduced 0.15%
49,475 $4.69 Million
Q3 2019

Nov 05, 2019

SELL
$85.54 - $94.26 $456,526 - $503,065
-5,337 Reduced 9.72%
49,550 $4.31 Million
Q2 2019

Aug 19, 2019

BUY
$75.4 - $92.8 $2,865 - $3,526
38 Added 0.07%
54,887 $5.01 Million
Q1 2019

May 08, 2019

SELL
$75.32 - $86.15 $57,167 - $65,387
-759 Reduced 1.36%
54,849 $5.27 Million
Q4 2018

Mar 01, 2019

SELL
$73.66 - $82.02 $82,278 - $91,616
-1,117 Reduced 1.97%
55,608 $4.77 Million
Q3 2018

Nov 19, 2018

BUY
$66.94 - $77.43 $51,878 - $60,008
775 Added 1.39%
56,725 $4.89 Million
Q2 2018

Aug 15, 2018

SELL
$64.91 - $73.36 $119,499 - $135,055
-1,841 Reduced 3.19%
55,950 $4.23 Million
Q1 2018

May 16, 2018

BUY
$70.39 - $84.15 $57,930 - $69,255
823 Added 1.44%
57,791 $4.67 Million
Q4 2017

Feb 20, 2018

SELL
$72.33 - $77.64 $296,263 - $318,013
-4,096 Reduced 6.71%
56,968 $4.78 Million
Q3 2017

Nov 15, 2017

BUY
$74.14 - $77.27 $55,234 - $57,566
745 Added 1.24%
61,064 $5.24 Million
Q2 2017

Aug 29, 2017

BUY
N/A
60,319
60,319 $5.04 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Griffin Asset Management, Inc. Portfolio

Follow Griffin Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.